Bone marrow transplant prep for children with non-cancer blood disorders
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism clinical trials.
This early-stage study tests a specific chemotherapy “conditioning” regimen to prepare the body for a bone marrow transplant in children with certain non-cancer blood or immune conditions. It may help the transplant work better, but it also carries risks from the chemotherapy and transplant process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under age 21
- Have a non-cancer diagnosis (blood/immune problem), such as specific hemoglobin disorders
- Have a close tissue match for the donor bone marrow/umbilical cord blood (about 8/8 match, or 5–8/8 for cord blood)
- Have enough organ function (lungs, kidneys, liver, and others) based on lab/medical tests
- Not be pregnant or breastfeeding, and have a negative pregnancy test if applicable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a safer “lighter” conditioning chemo plan before a bone marrow transplant for people with non-cancer blood and immune disorders. It aims to reduce transplant risk while using donor marrow that does not match perfectly in the HLA type.
This trial tests if removing a type of immune cell from a donor's stem cell graft can prevent graft-versus-host disease (GVHD) in children with certain non-cancer blood or immune disorders. It aims to make the transplant safer by reducing the risk of the donor cells attacking the child's body.
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
This trial tests whether removing certain immune cells (T cells) from the donor transplant can lower the risk of chronic graft-versus-host disease (long-term immune attack after transplant) in children and young adults with blood cancers. If you qualify, it may help improve transplant outcomes while tracking safety and side effects.
This trial tests a special immune-cell “preparation” treatment (called T-cell and B-cell depletion) with adjusted anti-thymocyte globulin (ATG) dosing before a stem cell transplant. It aims to reduce immune-related transplant complications in people under 25 with certain blood cancers in a specific remission status.
This trial studies how well a donor bone marrow (stem cell) transplant works for people with inherited immune system problems (called immune deficiencies). It’s for patients who haven’t improved with usual treatment or don’t have another good option.
Hear when a new Metabolic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.